Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

Dow Jones
2025/07/09

DJ Insulet Corp. Stock Underperforms Tuesday When Compared To Competitors

This article was automatically generated by MarketWatch using technology from Automated Insights.

Shares of Insulet Corp. (PODD) slipped 1.39% to $296.51 Tuesday, on what proved to be an all-around grim trading session for the stock market, with the S&P 500 Index falling 0.07% to 6,225.52 and Dow Jones Industrial Average falling 0.37% to 44,240.76.

This was the stock's third consecutive day of losses.

Insulet Corp. closed 9.97% short of its 52-week high of $329.33, which the company reached on May 21st.

The stock underperformed when compared to some of its competitors Tuesday, as Eli Lilly & Co. (LLY) rose 0.62% to $777.66, DexCom Inc. (DXCM) rose 0.99% to $83.76, and Johnson & Johnson $(JNJ)$ rose 0.33% to $155.79.

Trading volume (714,479) remained 170,696 below its 50-day average volume of 885,175.

Data source: Dow Jones Market Data, FactSet. Data compiled July 8, 2025.

This content was created by MarketWatch, which is operated by Dow Jones & Co. MarketWatch is published independently from Dow Jones Newswires and The Wall Street Journal.

 

(END) Dow Jones Newswires

July 08, 2025 17:07 ET (21:07 GMT)

Copyright (c) 2025 Dow Jones & Company, Inc.

應版權方要求,你需要登入查看該內容

免責聲明:投資有風險,本文並非投資建議,以上內容不應被視為任何金融產品的購買或出售要約、建議或邀請,作者或其他用戶的任何相關討論、評論或帖子也不應被視為此類內容。本文僅供一般參考,不考慮您的個人投資目標、財務狀況或需求。TTM對信息的準確性和完整性不承擔任何責任或保證,投資者應自行研究並在投資前尋求專業建議。

熱議股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10